NS EN ISO 22442-3 : 1ED 2007

Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 General requirements
  4.1 Risk management
  4.2 Sourcing and manufacturing process
  4.3 General requirements related to validation
5 Literature review
  5.1 Conduct of the literature review
  5.2 Application of literature review output
  5.3 Viruses
  5.4 TSE agents
6 Elimination and/or inactivation study of viruses and TSE
  agents
  6.1 General
  6.2 Protocol
  6.3 Conduct of the study
  6.4 Interpretation of data
7 Final report
8 Review of final report
9 Routine monitoring and control of critical process parameters
Annex A (normative) - Requirements related to literature review
Annex B (informative) - Guidance on the elimination and/or
                        inactivation study for viruses
Annex C (informative) - Guidance on the elimination and/or
                        inactivation study for TSE agents
Annex D (informative) - Guidance on scaling down
Annex E (informative) - Statistical evaluation of virus titres
                        and reduction factors and assessment of
                        their validity
Annex F (informative) - Calculation of reduction factors
Annex G (informative) - Probability of detection of agents at
                        low concentrations
Annex ZA (informative) - Relationship between this European
                         Standard and the Essential Requirements
                         of Directive 93/42/EEC as amended by
                         Commission Directive 2003/32/EC
Bibliography

Describes requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable.